QUEENSBURY, N.Y.--(BUSINESS WIRE)--AngioDynamics Inc. (NASDAQ:ANGO - News), a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, announced today that it will sponsor a symposium in New York City on January 22 during which doctors who have performed procedures using the Company’s recently-introduced NanoKnife™ system will share their experiences and patient outcomes.
NanoKnife is the first product offered by AngioDynamics that uses the new, potentially groundbreaking irreversible electroporation (IRE) technology. IRE technology is a non-thermal ablation technique for the resection of soft tissue. It has been described as “surgery at the cellular level.” The NanoKnife system uses electrical fields to create nano-scale defects in the membranes of targeted soft tissue, causing cell death only in the targeted tissue, without destroying critical structures such as ducts, blood vessels and nerves nearby.
Press release >> http://biz.yahoo.com/bw/090116/20090116005095.html?.v=1
Monday, January 19, 2009
AngioDynamics to Sponsor Symposium on First Human Clinical Experience with IRE Technology
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment